Talphera Secures Up to $29M in Private Placement Led by CorMedix.

lunes, 8 de septiembre de 2025, 2:54 pm ET1 min de lectura
CRMD--
TLPH--

Talphera has secured up to $29 million in a private placement led by CorMedix. The financing includes $17 million upfront and $12 million contingent on meeting certain conditions. The funds will support the advancement of Talphera's programs, including Niyad, a regional anticoagulant for CRRT. The investment positions Talphera to be fully financed through a potential approval of Niyad, expected in the second half of next year.

Talphera Secures Up to $29M in Private Placement Led by CorMedix.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios